Ironwood Pharmaceuticals, Inc.
IRWD
$3.73
$0.236.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 43.20% | 107.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 43.20% | 107.18% | |||
| Cost of Revenue | -3.87% | -14.80% | |||
| Gross Profit | 60.98% | 351.21% | |||
| SG&A Expenses | 30.44% | -30.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.48% | -22.29% | |||
| Operating Income | 72.36% | 527.25% | |||
| Income Before Tax | 79.84% | 204.27% | |||
| Income Tax Expenses | 96.44% | 1,176.75% | |||
| Earnings from Continuing Operations | 69.84% | 163.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 69.84% | 163.12% | |||
| EBIT | 72.36% | 527.25% | |||
| EBITDA | 71.63% | 552.21% | |||
| EPS Basic | 69.36% | 162.83% | |||
| Normalized Basic EPS | 86.36% | 311.05% | |||
| EPS Diluted | 66.96% | 159.17% | |||
| Normalized Diluted EPS | 85.92% | 293.02% | |||
| Average Basic Shares Outstanding | 0.30% | 0.47% | |||
| Average Diluted Shares Outstanding | 0.52% | 9.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||